Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vital Diagnostics, now integrated into ELITechGroup's Clinical Systems division, is a global leader in the development and manufacture of in vitro diagnostic (IVD) solutions. The company is best known for its Selectra and Envoy series of benchtop clinical chemistry analyzers, which provide automated testing for small to medium-sized laboratories. Their product portfolio includes a comprehensive range of liquid-stable reagents, calibrators, and controls designed for general chemistry, special proteins, and therapeutic drug monitoring. Following the acquisition of ELITechGroup by Bruker Corporation in 2024, the company's technologies continue to support decentralized laboratory testing and clinical diagnostics worldwide. Vital Diagnostics focuses on delivering reliable, easy-to-use systems that improve laboratory efficiency and diagnostic accuracy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vital Diagnostics.